ArticlePediatric blood & cancer2020
Initial report on Spanish pediatric oncologic, hematologic, and post stem cell transplantation patients during SARS-CoV-2 pandemic.
Abstract readLetterComment
In one paragraph
Article in Pediatric blood & cancer, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers, 6 of them syntheses that pooled it.
0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed, 6 pooled it
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
17 citing papers in PubMed, 6 syntheses or guidelines pooled it.
- COVID-19 infection in children with blood cancer: A systematic review.Annals of hematology · 2025Pooled it
- The impact of immunocompromise on outcomes of COVID-19 in children and young people-a systematic review and meta-analysis.Frontiers in immunology · 2023Pooled it
- A Portrait of SARS-CoV-2 Infection in Patients Undergoing Hematopoietic Cell Transplantation: A Systematic Review of the Literature.Current oncology (Toronto, Ont.) · 2022Pooled it
- The Global Impact of COVID-19 on Childhood Cancer Outcomes and Care Delivery - A Systematic Review.Frontiers in oncology · 2022Pooled it
- Pooled it
- Survival and Complications in Pediatric Patients With Cancer and COVID-19: A Meta-Analysis.Frontiers in oncology · 2020Pooled it
- Characteristics and Outcomes of Stem Cell Transplant Patients during the COVID-19 Era: A Systematic Review and Meta-Analysis.Healthcare (Basel, Switzerland) · 2024Review
- Caring for a child with cancer during COVID-19 pandemic: an assessment of the parents' perception and stress level.Frontiers in public health · 2024Article
- Article
- Immune Response following BNT162b2 mRNA COVID-19 Vaccination in Pediatric Cancer Patients.Cancers · 2023Article
- Secondary Impact of the Coronavirus Disease 19 Pandemic on Patients and the Cellular Therapy Healthcare Ecosystem.Transplantation and cellular therapy · 2022Review
- Clinical Characteristics and Outcomes of COVID-19 in Pediatric and Early Adolescent and Young Adult Hematopoietic Stem Cell Transplant Recipients: A Cohort Study.Transplantation and cellular therapy · 2022Article
- COVID-19 in Children with Cancer.Current oncology reports · 2022Review
- COVID-19 in children with haematological malignancies.Archives of disease in childhood · 2022Article
- COVID-19: Consequences for Children With Cancer in Turkey and Globally.Turkish archives of pediatrics · 2021Review
- COVID-19 infection in children with cancer and stem cell transplant recipients in Turkey: A nationwide study.Pediatric blood & cancer · 2021Article
- COVID-19 in Immunosuppressed Children.Frontiers in pediatrics · 2021Review
Corrections and comments
- Comment on
Authors and funding
32 authors.
Anna FauraPediatric Oncology and Hematology Department, Hospital Sant Joan de Deu, Barcelona, Spain.
Susana RivesPediatric Oncology and Hematology Department, Hospital Sant Joan de Deu, Barcelona, Spain.
Álvaro LassalettaPediatric Hematology-Oncology Department, Hospital Universitario Niño Jesús, Madrid, Spain.ORCID 0000-0003-2881-1473
Elena SebastiánPediatric Hematology-Oncology Department, Hospital Universitario Niño Jesús, Madrid, Spain.ORCID 0000-0002-5444-8076
Luis MaderoPediatric Hematology-Oncology Department, Hospital Universitario Niño Jesús, Madrid, Spain.ORCID 0000-0002-0708-1670
Jorge HuertaPediatric Hematology-Oncology Department, Hospital Materno-Infantil Gregorio Marañón, Madrid, Spain.ORCID 0000-0002-9209-6657
Marina García-MorínPediatric Hematology-Oncology Department, Hospital Materno-Infantil Gregorio Marañón, Madrid, Spain.
Antonio Pérez MartínezPediatric Hemato-Oncology Department, Hospital Universitario La Paz, Madrid, Spain.ORCID 0000-0001-7083-4316
Luisa SisinniPediatric Hemato-Oncology Department, Hospital Universitario La Paz, Madrid, Spain.
Itziar AstigarragaDepartment of Pediatrics, BioCruces Bizkaia Health Research Institute, Hospital Universitario Cruces, University of the Basque Country UPV/EHU, Barakaldo, Spain.
Pablo VelascoPediatric Oncology and Hematology, Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain.
Luis GrosPediatric Oncology and Hematology, Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain.
Lucas MorenoPediatric Oncology and Hematology, Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain.
Ana CarbonéPediatric Hemato-Oncology Department, Hospital Universitario Miguel Servet, Zaragoza, Spain.
Carmen Rodríguez-VigilPediatric Hemato-Oncology Department, Hospital Universitario Miguel Servet, Zaragoza, Spain.
Susana RiescoPediatric Hemato-Oncology Department, Hospital Clínico Universitario, Salamanca, Spain.
María Del Carmen MendozaPediatric Hemato-Oncology Department, Hospital Clínico Universitario, Salamanca, Spain.
Elena García MaciasPediatric Hemato-Oncology Department, Hospital Universitario Son Espases, Mallorca, Spain.
Maria TrabazoPediatric Oncology and Hematology Department, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain.
Montse TorrentPediatric Oncology and Hematology Department, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain.
Isabel BadellPediatric Oncology and Hematology Department, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain.
José Luis FusterPediatric Oncology and Hematology Department, Hospital Clínico Universitario Virgen de la Arrixaca, Instituto Murciano de Investigación Biosanitaria (IMIB), Murcia, Spain.
Nerea Dominguez-PinillaPediatric Oncology and Hematology Department, Hospital Virgen de la Salud, Toledo, Spain.
Antonio Juan RibellesPediatric Oncology and Hematology Unit, Hospital Universitario La Fe, La Valencia, Valencia, Spain.
Vanesa Pérez-AlonsoPediatric Oncology and Hematology Department, Hospital Universitario 12 de Octubre, Madrid, Spain.
Manuel Fernández SanmartínPediatric Oncology and Hematology Department, Hospital Clinico Universitario de Santiago de Compostela, Santiago de Compostela, Spain.
Marta BaragañoPediatric Oncology and Hematology Department, Hospital Universitario Quiron Salud, Madrid, Spain.
Maite GorosteguiPediatric Oncology and Hematology Department, Hospital Sant Joan de Deu, Barcelona, Spain.
Sara Perez-JaumePediatric Oncology and Hematology Department, Hospital Sant Joan de Deu, Barcelona, Spain.
Ana Fernández-TeijeiroPediatric Oncology and Hematology Department, Hospital Universitario Quiron Salud, Madrid, Spain.
Andrés Morales La MadridPediatric Oncology and Hematology Department, Hospital Sant Joan de Deu, Barcelona, Spain.ORCID 0000-0002-0592-673X
José Luis DapenaPediatric Oncology and Hematology Department, Hospital Sant Joan de Deu, Barcelona, Spain.
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Indexed as
BetacoronavirusCoronavirus InfectionsNeoplasmsPandemicsPneumonia, ViralAdolescentChildCOVID-19HumansSARS-CoV-2
Identifiers
What OpenQuestion holds
Textmetadata
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.